Clinical Trials Directory

Trials / Completed

CompletedNCT00533832

Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)

A Multicernter, Pivotal, Safety and Efficacy Study of the NeuroCtybernetic Prosthesis (NCP(R)) System in Patients With Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
266 (actual)
Sponsor
Cyberonics, Inc. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To confirm the safety and efficacy of the NCP System in treating patients in a nmajor depressive episode.

Conditions

Interventions

TypeNameDescription
DEVICEvagus nerve stimulation (VNS)intermittent vagus nerve stimulation Placebo group were implanted, but did not receive vagus nerve stimulation during the acute phase.

Timeline

Start date
2000-07-01
Completion
2005-07-01
First posted
2007-09-24
Last updated
2007-09-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00533832. Inclusion in this directory is not an endorsement.

Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) (NCT00533832) · Clinical Trials Directory